Cargando…

Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance

BACKGROUND: The long-term outcomes of ablation index (AI)-guided radiofrequency catheter ablation (RFCA) on atrial fibrillation (AF) and different subtypes of heart failure (HF) remain unknown. The aim of the study was to evaluate the long-term prognosis of AI-guided RFCA procedures in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Yu, Zhao, Zhen, Cai, Xiang, Guo, Yulong, Fu, Mingpeng, Liu, Ke, Guo, Jinrui, Guo, Tao, Niu, Guodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530740/
https://www.ncbi.nlm.nih.gov/pubmed/36204561
http://dx.doi.org/10.3389/fcvm.2022.922910
_version_ 1784801752392925184
author Qiao, Yu
Zhao, Zhen
Cai, Xiang
Guo, Yulong
Fu, Mingpeng
Liu, Ke
Guo, Jinrui
Guo, Tao
Niu, Guodong
author_facet Qiao, Yu
Zhao, Zhen
Cai, Xiang
Guo, Yulong
Fu, Mingpeng
Liu, Ke
Guo, Jinrui
Guo, Tao
Niu, Guodong
author_sort Qiao, Yu
collection PubMed
description BACKGROUND: The long-term outcomes of ablation index (AI)-guided radiofrequency catheter ablation (RFCA) on atrial fibrillation (AF) and different subtypes of heart failure (HF) remain unknown. The aim of the study was to evaluate the long-term prognosis of AI-guided RFCA procedures in patients with AF and concomitant HF. METHODS: We retrospectively included consecutive patients with AF and HF who underwent the initial RFCA procedure with AI guidance from March 2018 to June 2021 in our institution. The patients were categorized into two groups: HF with preserved ejection fraction (HFpEF) group and HF with mid-range ejection fraction (HFmrEF) +HF with reduced ejection fraction (HFrEF) group. RESULTS: A total of 101 patients were included. HFpEF and HFmrEF + HFrEF groups consisted of 71 (70.3%) and 30 patients (29.7%), respectively. During a median follow-up of 32.0 (18.2, 37.6) months, no significant difference was detected in AF recurrence between groups (21.1 vs. 33.3%) after multiple procedures, whereas the incidence of the composite endpoint of all-cause death, thromboembolic events, and HF hospitalization was significantly lower in HFpEF group (9.9 vs. 25.0%, Log-rank p = 0.018). In multivariable analysis, a history of hypertension [hazard ratio (HR) 4.667, 95% confidence interval (CI) 1.433–15.203, p = 0.011], left ventricular ejection fraction (LVEF) < 50% (HR 5.390, 95% CI 1.911–15.203, p = 0.001) and recurrent AF after multiple procedures (HR 7.542, 95% CI 2.355–24.148, p = 0.001) were independently associated with the incidence of the composite endpoint. CONCLUSION: Long-term success could be achieved in 75% of patients with AF and concomitant HF after AI-guided RFCA procedures, irrespective of different HF subtypes. Preserved LVEF was associated with a reduction in the composite endpoint compared with impaired LVEF. Patients with recurrent AF tend to have a poorer prognosis.
format Online
Article
Text
id pubmed-9530740
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95307402022-10-05 Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance Qiao, Yu Zhao, Zhen Cai, Xiang Guo, Yulong Fu, Mingpeng Liu, Ke Guo, Jinrui Guo, Tao Niu, Guodong Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: The long-term outcomes of ablation index (AI)-guided radiofrequency catheter ablation (RFCA) on atrial fibrillation (AF) and different subtypes of heart failure (HF) remain unknown. The aim of the study was to evaluate the long-term prognosis of AI-guided RFCA procedures in patients with AF and concomitant HF. METHODS: We retrospectively included consecutive patients with AF and HF who underwent the initial RFCA procedure with AI guidance from March 2018 to June 2021 in our institution. The patients were categorized into two groups: HF with preserved ejection fraction (HFpEF) group and HF with mid-range ejection fraction (HFmrEF) +HF with reduced ejection fraction (HFrEF) group. RESULTS: A total of 101 patients were included. HFpEF and HFmrEF + HFrEF groups consisted of 71 (70.3%) and 30 patients (29.7%), respectively. During a median follow-up of 32.0 (18.2, 37.6) months, no significant difference was detected in AF recurrence between groups (21.1 vs. 33.3%) after multiple procedures, whereas the incidence of the composite endpoint of all-cause death, thromboembolic events, and HF hospitalization was significantly lower in HFpEF group (9.9 vs. 25.0%, Log-rank p = 0.018). In multivariable analysis, a history of hypertension [hazard ratio (HR) 4.667, 95% confidence interval (CI) 1.433–15.203, p = 0.011], left ventricular ejection fraction (LVEF) < 50% (HR 5.390, 95% CI 1.911–15.203, p = 0.001) and recurrent AF after multiple procedures (HR 7.542, 95% CI 2.355–24.148, p = 0.001) were independently associated with the incidence of the composite endpoint. CONCLUSION: Long-term success could be achieved in 75% of patients with AF and concomitant HF after AI-guided RFCA procedures, irrespective of different HF subtypes. Preserved LVEF was associated with a reduction in the composite endpoint compared with impaired LVEF. Patients with recurrent AF tend to have a poorer prognosis. Frontiers Media S.A. 2022-09-20 /pmc/articles/PMC9530740/ /pubmed/36204561 http://dx.doi.org/10.3389/fcvm.2022.922910 Text en Copyright © 2022 Qiao, Zhao, Cai, Guo, Fu, Liu, Guo, Guo and Niu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Qiao, Yu
Zhao, Zhen
Cai, Xiang
Guo, Yulong
Fu, Mingpeng
Liu, Ke
Guo, Jinrui
Guo, Tao
Niu, Guodong
Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance
title Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance
title_full Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance
title_fullStr Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance
title_full_unstemmed Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance
title_short Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance
title_sort long-term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530740/
https://www.ncbi.nlm.nih.gov/pubmed/36204561
http://dx.doi.org/10.3389/fcvm.2022.922910
work_keys_str_mv AT qiaoyu longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance
AT zhaozhen longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance
AT caixiang longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance
AT guoyulong longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance
AT fumingpeng longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance
AT liuke longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance
AT guojinrui longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance
AT guotao longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance
AT niuguodong longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance